THE European Union is facing further shortfalls in its coronavirus inoculation programme after Anglo/Swedish pharmaceutical giant AstraZeneca said production problems and export restrictions would reduce planned deliveries of its vaccine.
AstraZeneca's image has already taken a hit with several countries suspending the rollout of its vaccine over blood clot fears, even as the World Health Organization said there was no reason to stop using it.
Denmark, Norway and Iceland have paused using the shot as a precaution and an Indian official on Saturday said the country would carry out a deeper review of its post-vaccination side effects next week.
AstraZeneca blamed production problems and export restrictions for the latest shortfall, a major setback in efforts to fight a pandemic that has claimed 2.6 million lives worldwide.
The company had previously warned it was facing shortfalls from its European supply chain due to "lower-than-expected output from the production process" and was hoping to compensate in part by sourcing vaccines from its global network.
"Unfortunately, export restrictions will reduce deliveries in the first quarter, and are likely to affect deliveries in the second quarter," it confirmed in a statement sent to AFP on Saturday.
- 'Unacceptable' -
AstraZeneca started delivery of the vaccine to the EU in February, and still aims to deliver 100 million doses in the first half of 2021.
Of this, 30 million are due to be delivered in the first quarter.
AstraZeneca had initially agreed to supply three times as many doses in the first quarter, and 180 million doses in second quarter alone.
The EU on Saturday sidestepped the issue of the number of AstraZeneca doses it was expecting. "We are aware that the company is experiencing supply issues and that discussions are on-going," it said.
Germany has already reported adverse effects due to the delay, the state of Thuringia cancelling appointments and suspending a pilot project for general practitioners to administer the vaccine.
Thuringia had been due to receive 31,200 doses next week, but the number has been reduced to 9,600.
The state's health minister, Heike Werner, called the delay "absolutely unacceptable".
French Prime Minister Jean Castex said his government still expected to exceed a target of 10 million vaccinated by April 15, though he deplored that some labs were not respecting delivery deadlines.
Castex defended the use of the AstraZeneca jab despite precautions taken by other nations.
"I would not allow myself to send poison to my fellow citizens," he said during a visit to a vaccination centre.
- A string of setbacks -
The United States has ramped up its vaccination programme after a shaky start.
The Centers for Disease Control and Prevention said 100 million vaccine doses had been administered in the US, which is around 30 percent of the total given worldwide so far.
Ethiopia also gave out its first doses of vaccine on Saturday, as the health ministry warned of an "alarming" increase in Covid-19 cases there.
Africa's second most populous country last week received 2.2 million doses of the AstraZeneca jab, manufactured by the Serum Institute of India, and will give jabs to health workers in the first phase.
AstraZeneca received further blows this week when several countries suspended use of its vaccine, while the EU's drug regulator said severe allergies should be added to the possible side effects.
The World Health Organization, which said its vaccines advisory committee was examining the safety data coming in, has stressed that no causal link has been established between the AstraZeneca vaccine and blood clotting.
"Yes, we should continue using the AstraZeneca vaccine," WHO spokeswoman Margaret Harris said Friday, stressing that any concerns over safety must be investigated.
AstraZeneca insisted its jab was safe, adding there is "no evidence" of higher blood clot risks.
Italy and Austria have banned the use of jabs from separate batches of AstraZeneca, and Thailand and Bulgaria said this week they would delay their rollout.
The shadow cast over the AstraZeneca jab is adding to the EU's problems distributing vaccines amid fears of another bout of the virus.
- 'Huge disparities' -
Austria, the Czech Republic, Slovenia, Bulgaria and Latvia meanwhile called for EU talks to discuss "huge disparities" in vaccine distribution, according to a letter published on Saturday.
The leaders of the countries sent the letter to the EU chiefs claiming that "deliveries of vaccine doses by pharma companies to individual EU member states are not being implemented on an equal basis."
"If this system were to carry on, it would continue creating and exacerbating huge disparities among member states by this summer, whereby some would be able to reach herd immunity in a few weeks while others would lag far behind," the letter said.
Italy on Friday announced tough new restrictions in much of the country, with Prime Minister Mario Draghi warning it faced "a new wave" of infections.
Schools, restaurants, shops and museums were ordered to close across most regions of Italy, including Rome and Milan from next week.
Disneyland Paris, one of Europe's biggest tourist attractions, said it will not be able to reopen as planned on April 2 as infections remain stubbornly high in France.
ETX Studio
Sun Mar 14 2021
WHO has stressed that no causal link has been established between the AstraZeneca vaccine and blood clotting. - REUTERS
Hayati perjuangan, jangan alpa kuasa dimiliki - Anwar
Presiden PKR Datuk Seri Anwar Ibrahim mengingatkan semua ahli terutama generasi muda supaya menghayati perjuangan parti dan tidak alpa dengan ‘kuasa’ yang dimiliki apabila menjadi pemerintah.
10 Berita Pilihan - (11 Mei 2024)
Antara pelbagai berita dalam dan luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
Berita tempatan pilihan sepanjang hari ini
Berikut adalah berita yang paling menjadi tumpuan sepanjang Sabtu, 11 Mei 2024.
Tumpuan Ahad - 12 Mei 2024
Ikuti rangkuman berita utama yang menjadi tumpuan di Astro AWANI.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
Malaysia dipilih semula sebagai Ahli Majlis Eksekutif Pertubuhan Larangan Senjata Kimia 2024-2026
Penggal berkenaan akan bermula daripada 12 Mei 2024 sehingga 11 Mei 2026.
Lawatan Anwar perkukuh hubungan dua hala Malaysia-Qatar
Perdana Menteri Datuk Seri Anwar Ibrahim akan melakukan lawatan rasmi ke Qatar dari 12 hingga 14 Mei untuk mengukuhkan lagi hubungan dan kerjasama di antara Malaysia dan Qatar di dalam pelbagai aspek, kata Kementerian Luar (Wisma Putra).
Guru didakwa kasari murid ditempatkan di pejabat pendidikan daerah
Seorang guru lelaki di sebuah sekolah agama di Pontian yang didakwa melakukan kekasaran terhadap sekumpulan murid akan ditempatkan di Pejabat Pendidikan Islam daerah.
TUDM dijangka bincang perolehan pesawat Hornet pada Jun depan
Tentera Udara Diraja Malaysia (TUDM) dijangka mengadakan lawatan ke Kuwait pada Jun depan bagi berunding mengenai perolehan pesawat tempur F/A-18D (Hornet).
Permohonan lesen membela kucing diwajibkan
Lembaga Perumahan dan Pembangunan (HDB) Singapura akan membenarkan penghuni flet miliknya untuk memohon lesen untuk memelihara kucing, berkuat kuasa September.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.